While the headline numbers don't inspire much confidence, Moderna is a stock that deserves a closer look. The company still ...

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu ...

Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for shares of Moderna in a note issued to investors ...

Moderna's been anything but a high-flying growth stock in this investor's portfolio. So is it high time he gave up on this ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the developme ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

The US dollar on Friday, January 17, ended trading at $157.50 down by 68 cents according to the Bank of Jamaica’s daily exchange trading summary. Meanwhile, the Canadian dollar ended at $­­­ 110.22 ...

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...